In addition, p-tau plasma assays appear to have a role in the differential diagnosis of AD from other dementia causing pathologies (130) while NFL has already been shown to be a dynamic marker of neurodegeneration which can be used to assess potential disease modification effects (131). Here, MAPT is linked to Alzheimer disease.